Global investment company KKR has signed agreements under which funds managed by KKR will acquire Indian medical devices company Healthium MedTech (Healthium).

Healthium will be acquired by a special purpose vehicle owned by KKR-managed funds, from an affiliate of Funds advised by global private equity advisory company Apax Partners.

The deal is valued at Rs70bn ($838.60m), reported Reuters, citing three sources with direct knowledge of the matter.

The special purpose vehicle will have a controlling stake in the Healthium Group, including Healthium Medtech.

Healthium was founded in 1992 and is engaged in developing, manufacturing and selling a broad range of surgical products worldwide.

Its comprehensive portfolio is designed to meet the wide spectrum of surgeons’ needs, offering arthroscopy, wound closure and advanced wound closure products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In 2018, Apax Funds acquired Healthium.

Healthium CEO Anish Bafna said: “Over the last five years, with the support and partnership of Apax, Healthium has tremendously accelerated its growth. Our products are now used in one-in-five surgeries globally and we have nearly doubled the markets we’re present in.

“As we look to further strengthen and expand our market position, we are delighted to welcome an investor of KKR’s calibre, who brings deep global healthcare expertise and knowledge of the Indian market.

“We look forward to our next phase of growth with their support, being able to leverage their global platform, as well as strong investment and operational expertise.”

Subject to receipt of certain regulatory approvals, the transaction is expected to close in the third quarter of 2024.

Jefferies is acting as financial adviser for Apax Partners and Healthium and Kirkland & Ellis as legal counsel.

Moelis & Company is serving as financial adviser for KKR while Simpson Thacher & Bartlett and AZB & Partners is acting as legal counsel.